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Theodor Boveri in 1914 recognized the significance of changes in the adhesion of tumor 
cells to the development of cancer. Cell adhesion is essential in all aspects of in verte-
brate cells such as cell growth, cell migration and cell differentiation. The majority of 
adhesion molecules fall into one of four families: cadherins, integrins, immunoglobulin 
superfamily (IgSF) and selectins. The cadherins are a family of homophilic CAMs (cell 
adhesion moleculs), Ca2+ dependent. The most important members of cadherins are E-
cadherins (epithelial), P-cadherins (placental) and N-cadherins (neural). Immunoglobu-
lin superfamily CAMs (IgSF CAMs) are either homophilic or heterophilic and bind in-
tegrins, growth factor receptors cadherins or different IgSF CAMs. The integrins are a 
family of heterophilic CAMs that bind IgSF CAMs or the extracellular matrix. The se-
lectins are a family of heterophilic CAMs that bind fucosylated carbohydrates, e.g. mu-
cins. They are calcium-dependent. The three family members are E-selectin (endothelial 
(, L-selectin (leukocyte) and P-selectin (platelet). Recent experimental results indicate 
that, as well as mediating intercellular and cell–matrix interactions, cell-adhesion mole-
cules also directly modulate signal transduction. Changes in the expression or function 
of cell-adhesion molecules can therefore contribute to tumor progression via altering the 
adhesion status of the cell or affecting cell signaling. The ability to colonize a specific 
organ has been correlated with the preferential adhesion of the cancer cells to endotheli-
al cells derived from the target organ. This review summarizes recent findings about role 
of adhesion molecules in the tumor progression. 
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Cadherin superfamily consists of classical and non-
classical cadherins. Classical cadherins are the main 
mediators of calcium-dependent cell–cell adhesion. 
Non-classical cadherins include desmosomal cadherins 
and the recently discovered large subfamily of 
protocadherins, which are implicated in neuronal 
plasticity. The functional role of non-classical 
cadherins in tumor progression is unknown. Most 
human cancers originate from epithelial tissue (1, 2).  
In most, if not all, cancers of epithelial origin, E-
cadherin-mediated cell–cell adhesion is lost 
concomitantly with progression towards towards 
tumor malignancy. There is an inverse correlation 
between E-cadherin levels, tumor grade and patient 
mortality rates. Loss of E-cadherin function elicits 
active signals that support tumor-cell migration, 
invasion and metastatic dissemination. The loss of 
E-cadherin function during tumor progression  
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Ig-CAMs 
The immunoglobulin 
superfamily is a large 
group of cell surface 
and soluble proteins 
that are involved in the 
recognition, binding or 
adhesion processes of 
cells. In table 1 has 
been shown 
involvement of Ig-
CAMs in tumour 
progression (1). 
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CAM Tumor type Changes in expres-
sion  during tumor 
progression 
NCA
M 
Pancreatic and colon cancer, astrocytoma 
Neuroblastoma, certain neuroendocrine tumours 
Downregulated 
Upregulated 
L1 Melanoma, breast and prostate cancer Upregulated 
DCC 
Colorectal cancer, pancreatic cancer, neuroblasto-
ma, various carcinomas Downregulated 
CEA Various carcinomas Upregulated 
CEA-
CAM1 
Carcinoma of the prostate, breast, colon and 
endometrium Downregulated 
Mel-
CAM 
Melanoma, prostate cancer 
Breast cancer 
Upregulated 
Downregulated 
NrCA
M 
Glioblastoma 
Pancreatic cancer 
Upregulated 
Downregulated 
CAM, cell-adhesion molecule; CEA, carcinoembryonic antigen; DCC, deleted in colo-
rectal cancer; Ig-CAM, immunoglobulin-like CAM; Mel-CAM, melanoma CAM; 
NCAM, neural CAM; NrCAM, neuronal CAM. 
can be caused by various genetic or epigenetic mechanisms includ-
ing: mutation, E-cadherin expression is down regulated at the tran-
scriptional level, E-cadherin gene locus hyper methylation and pro-
teolytic degradation by MMPs (Matrix Metalloproteinases) (3). Loss 
of E-cadherin triggers active signals that initiate EMT (Epithelial 
Mesenchymal Transition). Mechanisms of E-cadherin signaling 
were included modulation of RTK signaling, activation of the WNT 
signaling pathway and signaling through RHO GTPases (4). In mel-
anoma, prostate and breast cancer, loss of E-cadherin function is 
accompanied by the gain of expression of mesenchymal cadherins, 
for example, neuronal (N)-cadherin and cadherin-11, in a process 
that is known as the cadherin switch. N-cadherin has been shown to 
promote cell motility and migration — an opposite effect to that of E
-cadherin. N-cadherin-induced tumor-cell invasion can even over-
come E-cadherin-mediated cell-cell adhesion. N-cadherin facilitates 
binding of FGF2 to the receptor. It can serve as a surrogate ligand 
for FGFR. Also N-cadherin recruits PI3K to the adhesion complex, 
resulting in the activation of AKT (also known as protein kinase B) 
and increased cell survival. VE-cadherin is a non-classical cadherin 
that is specifically expressed in endothelial cells. It associates with 
vascular endothelial growth factor receptor-2 (VEGFR2) and modu-
lates its signaling activities. VE-cadherin contributes in the develop-
ment and integrity of the vascular network (5). 
Table 1 | Involvement of Ig-CAMs in tumor progression 
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NCAM was expressed in many cell types, including 
epithelial cells of various organs, muscle cells and 
pancreatic β-cells. The biological significance of this 
change in NCAM expression and its role in tumor onset 
and/or progression are not understood. NCAM (Neural 
CAM) associates with FGFRs. Loss of NCAM function 
during tumor progression affects cell–matrix adhesion 
through the loss of FGFR-induced, integrin-mediated cell–
matrix adhesion. Cell-adhesion molecules of the CEA 
(Carcinoembryonic Antigen) family have long been thought 
to have a role in tumorigenesis. Functional role in tumor 
development is not known. CEACAM1 modulates the 
angiogenic process via induce neovascularization in certain 
experimental systems and it acts as an anti-angiogenic 
factor in prostate cancer (1, 6). The gene encoding the DCC 
(Deleted in Colorectal Cancer) Ig-CAM was originally 
identified as a tumor suppressor, because of the high 
frequency of LOH (Loss of Heterozygosity) of this gene in 
colorectal cancer. DCC has been reported to induce 
apoptosis. L1 has functional similarities to NCAM.    The 
expression of L1 is also up regulated in certain tumor types 
(7). 
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 Integrins 
Integrins are structurally organized into heterodimeric transmembrane complexes variously assembled through 
the non-covalent association between an α and a β subunit. So far, 18 α subunits, 8 β subunits, and 24 or 25 
complexes have been identified. Cytoplasmic tails of integtins modulate receptor distribution, receptor surface 
expression, ligand binding affinity of the extracellular domain, cell adhesion, and cell spreading. Integrins are 
crucial regulators of differentiation, growth, survival, migration and invasion (8). They can mediate cell-ECM 
interaction and cell-cell interaction. By interacting with the ECM and, inside the cell, with the cytoskeleton, 
integrins transfer signals from the extracellular environment to intracellular compartments and control many 
cellular functions, such as migration, survival, proliferation, differentiation, and gene expression. Cell adhesion 
to the ECM is required for cell cycle progression and proliferation in different cell types.Loss of cell 
anchorage to the ECM has been shown to up-regulate the expression of cyclin kinase inhibitors (CKIs) 
such as p27/kip1, while at the same time decreasing the levels of cyclin D1 and A. There are metastatic 
melanoma cells that express little or no αVβ3 integrin on their surface suggesting that no single adhesion 
receptor is irreplaceable in melanoma progression (9). The best characterized signaling pathways that activated 
by integrins are the FAK, PI3-kinase and Ras/MAP kinase. Integrin signaling pathways that control cell 
migration are altered in prostate cancer (10).  
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8. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69
(1):11-25. 
. 
-Integrins are involved in the pathogenesis of bone metastasis at many levels and further study to define 
integrin dysregulation by cancer will yield new therapeutic targets for the prevention and treatment of bone 
metastasis. 
 
Selectins 
Selectins, a family of mammalian lectins engaged in adhesion reactions are expressed by leukocytes, 
endothelial cells, and platelets. Slectins interact with cell-surface glycoconjugates and mediate rolling and 
adhesion of several types of cells (11). L-selectin is constitutively expressed by leukocytes, E-selectin by 
activated endothelial cells and P-selectin by platelets and activated endothelial cells. P-selectin (CD62P) is 
expressed on the membrane of endothelial cells and platelets following cellular activation. P-selectin binds to 
several types of human cancer cells such as colon, lung and breast cancer, as well as to melanoma and 
neuroblastoma. The potential role of P-selectin in metastasis it was suggested that targeting P-selectin may 
offer novel therapeutic strategies to treat metastatic cancer. P-selectin bind to several human cancer cells 
including: neuroblastoma, colon cancer, breast cancer, malignant melanoma, gastric cancer and lung cancer. L-
selectin (CD62L), is structurally and functionally similar to other selectins. L-selectin is essential for homing 
of lymphocytes to secondary lymphoid organs. L-selectin is constitutively expressed on most leukocytes. 
Tumor cells express sialomucins that can serve as L, P or E-selectin ligands. The role of selectins in tumor 
progression included: interaction of tumor cells with platelets and leukocytes resulting in the formation of 
circulating emboli, interaction of tumor cells with endothelial cells leading to extravasation of tumor cells and 
utilization of reciprocal pro malignancy signals delivered by the selectins or by their ligands to interacting cells 
that express the corresponding co-receptor. Platelets play multiple roles in tumor progression and metastasis. 
Together with leukocytes, they form aggregates with circulating tumor cells thereby protecting the tumor cells 
from immune insults and shear stress.  
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The aggregates also facilitate the binding of tumor cells to 
endothelial cells thereby promoting extravasation. L-selectin 
enhances metastasis by recruiting leukocytes to platelet tumor 
emboli in the circulation. The increased size of the emboli could 
facilitate their mechanical trapping in the microvasculature. L-
selectin expressing leukocytes could bridge the emboli to the 
vascular endothelial cells expressing L-selectin      ligands. They 
facilitate metastasis by induction of as yet unidentified L-selectin 
ligands on endothelial cells via fucosyltransferase-7. In 
colorectal cancer E-selection expression is upregulated on 
endothelial cells that are located in close physical contact to 
invading tumor cells. This is probably due to the secretion of pro 
inflammatory cytokines by the invading tumor cells (11-13). 
